1. Home
  2. MITQ vs SNGX Comparison

MITQ vs SNGX Comparison

Compare MITQ & SNGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MITQ
  • SNGX
  • Stock Information
  • Founded
  • MITQ N/A
  • SNGX 1987
  • Country
  • MITQ United States
  • SNGX United States
  • Employees
  • MITQ N/A
  • SNGX N/A
  • Industry
  • MITQ Telecommunications Equipment
  • SNGX Biotechnology: Pharmaceutical Preparations
  • Sector
  • MITQ Telecommunications
  • SNGX Health Care
  • Exchange
  • MITQ Nasdaq
  • SNGX Nasdaq
  • Market Cap
  • MITQ 8.0M
  • SNGX 7.4M
  • IPO Year
  • MITQ 2021
  • SNGX 1987
  • Fundamental
  • Price
  • MITQ $0.70
  • SNGX $2.32
  • Analyst Decision
  • MITQ
  • SNGX
  • Analyst Count
  • MITQ 0
  • SNGX 0
  • Target Price
  • MITQ N/A
  • SNGX N/A
  • AVG Volume (30 Days)
  • MITQ 4.5M
  • SNGX 618.6K
  • Earning Date
  • MITQ 02-18-2025
  • SNGX 03-14-2025
  • Dividend Yield
  • MITQ N/A
  • SNGX N/A
  • EPS Growth
  • MITQ N/A
  • SNGX N/A
  • EPS
  • MITQ N/A
  • SNGX N/A
  • Revenue
  • MITQ $18,756,000.00
  • SNGX $364,183.00
  • Revenue This Year
  • MITQ N/A
  • SNGX N/A
  • Revenue Next Year
  • MITQ N/A
  • SNGX $76.64
  • P/E Ratio
  • MITQ N/A
  • SNGX N/A
  • Revenue Growth
  • MITQ N/A
  • SNGX N/A
  • 52 Week Low
  • MITQ $0.42
  • SNGX $1.83
  • 52 Week High
  • MITQ $1.55
  • SNGX $14.88
  • Technical
  • Relative Strength Index (RSI)
  • MITQ 48.16
  • SNGX 36.12
  • Support Level
  • MITQ $0.68
  • SNGX $2.23
  • Resistance Level
  • MITQ $0.76
  • SNGX $2.39
  • Average True Range (ATR)
  • MITQ 0.05
  • SNGX 0.17
  • MACD
  • MITQ -0.01
  • SNGX 0.01
  • Stochastic Oscillator
  • MITQ 25.97
  • SNGX 22.12

About MITQ Moving iMage Technologies Inc.

Moving iMage Technologies Inc is engaged in providing designed equipment as well as other off the shelf cinema products needed for contemporary cinema requirements. It offers technical, design and consulting services such as custom engineering, systems design, integration and installation and digital technology, as well as software solutions for operations enhancement and theatre management.

About SNGX Soligenix Inc.

Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely Specialized BioTherapeutics and Public Health Solutions. It generates maximum revenue from Public Health Solutions with active development programs for RiVax, its ricin toxin vaccine candidate, SGX943, its therapeutic candidate for antibiotic resistant and emerging infectious disease, and its research programs to identify and develop novel vaccine candidates targeting viral infection including Ebola, Marburg and SARS-CoV-2 (the cause of COVID-19).

Share on Social Networks: